338 results on '"Lee, Yena"'
Search Results
2. Co-culture platform for neuron-astrocyte interaction using optogenetic modulation
3. Synthesis of a dual-emissive pyrene-based fluorescent probe for imaging intracellular viscosity
4. Integrated production and inventory routing planning of oxygen supply chains
5. Optimisation frameworks for integrated planning with allocation of transportation resources for industrial gas supply chains
6. Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis
7. Microbiome abnormalities as a possible link between diabetes mellitus and mood disorders: Pathophysiology and implications for treatment
8. Sex differences in ketamine's therapeutic effects for mood disorders: A systematic review
9. Clinical and genetic analyses of patients with lateralized overgrowth
10. Whole-body MRI evaluation in neurofibromatosis type 1 patients younger than 3 years old and the genetic contribution to disease progression
11. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis
12. Unfavorable clinical outcomes in patients with carbamoyl phosphate synthetase 1 deficiency
13. Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: Results from the canadian rapid treatment center of excellence
14. Onset and frequency of depression in post-COVID-19 syndrome: A systematic review
15. Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effects
16. Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of Excellence
17. Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series
18. The effect of intravenous ketamine on cognitive functions in adults with treatment-resistant major depressive or bipolar disorders: Results from the Canadian rapid treatment center of excellence (CRTCE)
19. Cardiosphere-derived cells, with and without a biological scaffold, stimulate myogenesis and recovery of muscle function in mice with volumetric muscle loss
20. Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders
21. Peripheral inflammatory biomarkers define biotypes of bipolar depression
22. The Prevalence of Suicidal Behaviour in Fibromyalgia Patients
23. The effect of repeated doses of intravenous ketamine on measures of workplace attendance and productivity in adults with major depressive and bipolar disorder: Results from the canadian rapid treatment center of excellence
24. Validation of the McIntyre And Rosenblat Rapid Response Scale (MARRRS) in Adults with Treatment-Resistant Depression Receiving Intravenous Ketamine Treatment
25. The impact of overweight/obesity on monetary reward processing: A systematic review
26. A Systematic review of the validity of screening depression through Facebook, Twitter, Instagram, and Snapchat
27. Intravenous ketamine for postmenopausal women with treatment-resistant depression: Results from the Canadian Rapid Treatment Center of Excellence
28. Loneliness-based impaired reward system pathway: Theoretical and clinical analysis and application
29. Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence
30. Ecological momentary assessment of depressive symptoms using the mind.me application: Convergence with the Patient Health Questionnaire-9 (PHQ-9)
31. A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusions
32. Insulin resistance is associated with deficits in hedonic, self-reported cognitive, and psychosocial functional response to antidepressant treatment in individuals with major depressive disorder
33. Effects of infliximab on brain neurochemistry of adults with bipolar depression
34. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis
35. Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment
36. The Meaningful Change Threshold as Measured by the 16-Item Quick Inventory of Depressive Symptomatology in Adults with Treatment-Resistant Major Depressive and Bipolar Disorder Receiving Intravenous Ketamine
37. The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future Research
38. Exploring brain insulin resistance in adults with bipolar depression using extracellular vesicles of neuronal origin
39. The influence of prescriber and patient gender on the prescription of benzodiazepines: evidence for stereotypes and biases?
40. Clinical and molecular spectra of BRAF-associated RASopathy
41. The Effect of Loneliness on Distinct Health Outcomes: A Comprehensive Review and Meta-Analysis
42. Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: Results from the Canadian Rapid Treatment Center of Excellence
43. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis
44. Leptin mediates improvements in cognitive function following treatment with infliximab in adults with bipolar depression
45. The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence
46. The utility of smartphone-based, ecological momentary assessment for depressive symptoms
47. Projected increases in suicide in Canada as a consequence of COVID-19
48. Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I/II depression
49. What is bipolar disorder? A disease model of dysregulated energy expenditure
50. Using early changes in cold cognition to predict response to vortioxetine in major depressive disorder
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.